Teriflunomide is an active pharmaceutical ingredient and the active metabolite of leflunomide. It was investigated in a Phase III clinical trial for multiple sclerosis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 163451-81-8
Vilazodone hydrochloride
pharmaceutical raw material
Vilazodone
pharmaceutical raw material
Pazufloxacin mesilate
pharmaceutical raw material
Cangrelor
pharmaceutical raw material
2-Cyano-3-hydroxy-N-(4-trifluoromethylphenyl)crotonamide
pharmaceutical intermediate
(Z)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide
UTNUDOFZCWSZMS-YFHOEESVSA-N
C/C(=C(\C#N)/C(=O)NC1=CC=C(C=C1)C(F)(F)F)/O